A great two days at ‘Safety of Stem Cell-Derived Therapies: Trends in Future Technologies’ in Edinburgh that Sistemic attended on October 7-8 2019

Release Date: October 10, 2019





Excellent speakers, content and presentations highlighting the safety issue of residual pluripotent stem cells in derived cell therapies and the regulatory requirement for an assay.

It was great meeting everyone at our Stand and discussing how our SistemPSCCheck™ assay can help them in addressing this critical safety issue and support the development of their innovative derived cell therapies.